United Services Automobile Association Invests $472,000 in Doximity, Inc. $DOCS

Key Points

• United Services Automobile Association acquired 8,070 shares of Doximity, Inc. valued at approximately $472,000 during the first quarter, indicating increased interest from institutional investors.
• Doximity's stock reported a 0.7% decline, with its current price at $69.01, while the company has a market capitalization of $12.92 billion.
• The company recently reported earnings per share (EPS) of $0.36 for the last quarter, surpassing analyst expectations and reflecting a 15.2% year-over-year revenue increase.

United Services Automobile Association acquired a new position in Doximity, Inc. (NASDAQ:DOCS - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 8,070 shares of the company's stock, valued at approximately $472,000.

Other large investors have also recently made changes to their positions in the company. VSM Wealth Advisory LLC acquired a new position in shares of Doximity in the 1st quarter worth approximately $29,000. Allworth Financial LP lifted its holdings in shares of Doximity by 104.0% in the 1st quarter. Allworth Financial LP now owns 563 shares of the company's stock worth $32,000 after acquiring an additional 287 shares during the last quarter. National Bank of Canada FI acquired a new position in shares of Doximity in the 1st quarter worth approximately $33,000. Spire Wealth Management lifted its holdings in shares of Doximity by 73.2% in the 1st quarter. Spire Wealth Management now owns 615 shares of the company's stock worth $36,000 after acquiring an additional 260 shares during the last quarter. Finally, Brooklyn Investment Group lifted its holdings in shares of Doximity by 70.7% in the 1st quarter. Brooklyn Investment Group now owns 746 shares of the company's stock worth $43,000 after acquiring an additional 309 shares during the last quarter. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, Director Kira Scherer Wampler sold 2,000 shares of the firm's stock in a transaction on Friday, August 1st. The shares were sold at an average price of $57.09, for a total value of $114,180.00. Following the completion of the sale, the director owned 16,618 shares in the company, valued at approximately $948,721.62. This trade represents a 10.74% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Timothy S. Cabral sold 10,000 shares of the firm's stock in a transaction on Wednesday, June 25th. The stock was sold at an average price of $60.00, for a total transaction of $600,000.00. Following the completion of the sale, the director owned 6,360 shares of the company's stock, valued at $381,600. This trade represents a 61.12% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 32,000 shares of company stock worth $1,929,380 in the last 90 days. Company insiders own 31.30% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on DOCS. Needham & Company LLC upped their price objective on shares of Doximity from $67.00 to $75.00 and gave the stock a "buy" rating in a report on Friday, August 8th. Piper Sandler increased their target price on shares of Doximity from $65.00 to $69.00 and gave the stock an "overweight" rating in a report on Monday, August 11th. KeyCorp increased their target price on shares of Doximity from $65.00 to $70.00 and gave the stock an "overweight" rating in a report on Monday, July 14th. BTIG Research upgraded shares of Doximity from a "neutral" rating to a "buy" rating and set a $80.00 target price on the stock in a report on Monday, June 2nd. Finally, The Goldman Sachs Group set a $50.00 target price on shares of Doximity and gave the stock a "neutral" rating in a report on Wednesday, May 21st. Two equities research analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and eleven have assigned a Hold rating to the company's stock. Based on data from MarketBeat, Doximity currently has an average rating of "Moderate Buy" and a consensus price target of $67.00.

Doximity Trading Down 0.6%

Shares of NASDAQ DOCS traded down $0.47 during mid-day trading on Tuesday, reaching $72.00. The company had a trading volume of 358,153 shares, compared to its average volume of 2,210,229. The firm has a 50 day simple moving average of $63.84 and a two-hundred day simple moving average of $59.78. The stock has a market cap of $13.49 billion, a P/E ratio of 71.98, a PEG ratio of 4.10 and a beta of 1.37. Doximity, Inc. has a 52-week low of $39.62 and a 52-week high of $85.21.

Doximity (NASDAQ:DOCS - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, topping analysts' consensus estimates of $0.31 by $0.05. Doximity had a net margin of 36.60% and a return on equity of 21.75%. The business's revenue for the quarter was up 15.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.28 earnings per share. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. On average, equities analysts expect that Doximity, Inc. will post 0.99 EPS for the current year.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.